| Info. | Vol.17 - No.1 (2023.03.20) |
|---|---|
| Title | Organ-On-A-Chip Technology: An In-depth Review of Recent Advancements and Future of Whole Body-on-chip |
| Authors | Rishab Driver1, Shweta Mishra1 *Shweta Mishra Mishrashweta264@gmail.com |
| Institutions | 1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s, NMIMS, V.L Mehta Road, Vile Parle (W), Mumbai 400056, India |
| Abstract | One of the leading challenges facing the pharmaceutical industry today is the ‘high attrition rate problem’, with a large number of drug candidates being abandoned before reaching the clinical stage. The high failure rate is not only costly for the pharmaceutical industry but also hinders the access of patients to better treatment options. This ever-widening gap can be attributed to the current in-vitro and animal testing techniques for predicting human responses to drug candidates. Twodimensional (2D) in-vitro cell culture fails to recapitulate key physical and biochemical cues while phylogenetic differences between animal models and humans in key physiological systems make data generated by these platforms unreliable. There have been several solutions proposed but one that has been gaining a lot of prominence are microfluidic-based microsystems able to mimic organs, called ‘Organ-On-A-Chip’ devices and is built upon the principles of microfluidics, material science, and cell biology. Here we delve into the ongoing research involving this platform demonstrating its key strengths and the application of this technology in several key stages of drug discovery such as target identification and high throughput screening. We also discuss the potential, future, and key obstacles that lie in the universal adoption of this technology. |
| Keyword | Organ-On-A-Chip, Microfluidic chip, Microfluidics, Physiological model, 3D culture, Toxicity profile |
| PDF File |
 # 2010년도 발행분 부터는 Springer 의 BioChip Journal 페이지에서 전문을 열람하실 수 있습니다.
# 학회회원 로그인 후 [ Springer BioChip Journal 열람하기 ] 버튼을 클릭하시면 새창으로 열립니다. |
